  AIAltMed is a cutting-edge platform designed for drug discovery and
repurposing. It utilizes Tanimoto similarity to identify structurally similar
non-medicinal compounds to known medicinal ones. This preprint introduces
AIAltMed, discusses the concept of `AI-driven alternative medicine,' evaluates
Tanimoto similarity's advantages and limitations, and details the system's
architecture. Furthermore, it explores the benefits of extending the system to
include PubChem and outlines a corresponding implementation strategy.
